يعرض 1 - 20 نتائج من 66 نتيجة بحث عن '"Blanco, Remei"', وقت الاستعلام: 0.50s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal

    المساهمون: Blanco R Servei d’Oncologia Mèdica, Consorci Sanitari de Terrassa, Terrassa, Spain. Dómine M Department of Medical Oncology, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain. González JL Department of Medical Oncology, Hospital Clínico San Carlos, Madrid, Spain. Loutfi S Servei de Geriatria, Hospital de Terrassa, Consorci Sanitari de Terrassa, Terrassa, Spain. Alfaro J Servei d’Oncologia Mèdica, Hospital de Terrassa, Consorci Sanitari de Terrassa, Terrassa, Spain. Saldaña J Department of Medical Oncology, Oncobell Program, Institut Català d'Oncologia, L'Hospitalet de Llobregat, Spain, Consorci Sanitari de Terrassa

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Lung Cancer;183; https://doi.org/10.1016/j.lungcan.2023.107318; Blanco R, Dómine M, González JL, Loutfi S, Alfaro J, Saldaña J, et al. Pembrolizumab as first-line treatment for advanced NSCLC in older adults: A phase II clinical trial evaluating geriatric and quality-of-life outcomes. Lung Cancer. 2023 Sep;183:107318.; https://hdl.handle.net/11351/10200

  3. 3
    Academic Journal

    المساهمون: Provencio M, Calvo V Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain. Ortega AL Medical Oncology Department, Hospital Universitario de Jaén, Jaén, Spain. Coves-Sarto J Medical Oncology Department, Hospital Universitari Son Llàtzer, Palma de Mallorca, Spain. Marsé-Fabregat R Medical Oncology Department, Hospital Universitari Son Espases, Palma de Mallorca, Spain. Dómine M Cancer Research Area, Instituto de Investigación Sanitaria, Fundación Jiménez Díaz, Madrid, Spain. Blanco R Servei d’Oncologia, Hospital de Terrassa, Consorci Sanitari de Terrassa, Terrassa, Spain, Consorci Sanitari de Terrassa

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: JAMA Oncology;9(3); https://doi.org/10.1001/jamaoncol.2022.5959; Provencio M, Calvo V, Ortega AL, Coves-Sarto J, Marsé-Fabregat R, Dómine M, et al. Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer With High Tumor Mutation Burden: A Nonrandomized Controlled Trial. JAMA Oncol. 2023 Mar 1;9(3):344-53.; https://hdl.handle.net/11351/10059

  4. 4
    Academic Journal

    مصطلحات موضوعية: Càncer

    وصف الملف: application/pdf

    Relation: BMC Cancer, 2022; Provencio Pulla, Mariano Cobo, Manuel Rodriguez-Abreu, Delvys Calvo, Virginia Carcereny, Enric Cantero, Alejandra Bernabé, Reyes Benitez, Gretel López Castro, Rafael Massutí Sureda, Bartomeu Barco, Edel Garcia Campelo, Rosario Guirado, Maria Camps Herrero, Carlos Ortega, Ana Laura González Larriba, Jose Luís Sánchez, Alfredo Casal, Joaquín Sala, M. Angeles Juan Vidal, Oscar Bosch Barrera, Joaquim Oramas, Juana Dómine, Manuel Trigo, Jose Manuel Blanco, Remei Calzas, Julia Morilla, Idoia Padilla, Airam Torrente, Maria 2022 Determination of essential biomarkers in lung cancer: a real-world data study in Spain. BMC Cancer; https://hdl.handle.net/10550/82667; 152448

  5. 5
    Academic Journal

    مصطلحات موضوعية: Càncer, Pulmons

    وصف الملف: application/pdf

    Relation: BMC Cancer, 2022, vol. 22, num. 732; Provencio Pulla, Mariano Cobo, Manuel Rodriguez-Abreu, Delvys Calvo, Virginia Carcereny, Enric Cantero, Alejandra Bernabé, Reyes Benítez, Gretel López Castro, Rafael Massutí Sureda, Bartomeu Barco, Edel Garcia Campelo, Rosario Guirado, Maria Camps Herrero, Carlos Ortega, Ana Laura González Larriba, Jose Luís Sánchez, Alfredo Casal, Joaquín Sala, M. Angeles Juan Vidal, Oscar Bosch Barrera, Joaquim Oramas, Juana Dómine, Manuel Trigo, Jose Manuel Blanco, Remei Calzas, Julia Morilla, Idoia Padilla, Airam Torrente, Maria 2022 Determination of essential biomarkers in lung cancer : a real-world data study in Spain with demographic, clinical, epidemiological and pathological characteristics BMC Cancer 22 732; https://hdl.handle.net/10550/83471; 154245

  6. 6
    Academic Journal

    المساهمون: Gutiérrez L Medical Oncology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain. Royuela A Biostatistics Unit, Puerta de Hierro Biomedical Research Institute, CIBERESP, Madrid, Spain. Carcereny E Catalan Institute of Oncology, Hospital Universitari Germans Trias i Pujol, B-ARGO, IGTP, Badalona, Spain. López-Castro R Hospital Clínico Universitario de Valladolid, Valladolid, Spain. Rodríguez-Abreu D Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain. Massuti B Hospital General Universitario de Alicante, Alicante, Spain. Blanco R Servei d’Oncologia, Hospital de Terrassa, Consorci Sanitari de Terrassa, Terrassa, Spain, Consorci Sanitari de Terrassa

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: BMC Cancer;21(1); https://doi.org/10.1186/s12885-021-08713-8; Gutiérrez L, Royuela A, Carcereny E, López-Castro R, Rodríguez-Abreu D, Massuti B, et al. Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data. BMC Cancer. 2021 Aug 31;21(1):977.; https://hdl.handle.net/11351/10384

  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
  13. 13
    Academic Journal
  14. 14
  15. 15
    Academic Journal
  16. 16
    Academic Journal
  17. 17
  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20